Novo's Ozempic, Wegovy picked for US Medicare price negotiations
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027, the U.S. government said on Friday, part of a law pharmaceutical companies have pledged to revisit with the Trump administration.
In other news, Novo Nordisk announced the results from its phase 3b STEP UP semaglutide trial today. Specifically, the ...
The White House on Friday said Novo Nordisk’s weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a ...
We recently published a list of These 10 Firms Took A Hit on Friday. In this article, we are going to take a look at where ...
The U.S. Department of Agriculture is urging poultry producers to intensify bird flu testing. The WHO is advocating for U.S.
European stocks advanced for four consecutive weeks as miners rose on a report Rio Tinto Group and Glencore Plc have ...
President-elect Donald Trump says he “most likely” will give TikTok 90 more days to work out a deal that would allow the ...
You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...
Hosted on MSN13h
US Stocks Notch First Weekly Gain This Year Before Trump’s Inauguration, Executive OrdersU.S. stocks closed higher on Friday, securing the first weekly advance of the year, as investors anticipated a busy start to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback